Skip to main content
Map of Blessing Hospital and nearby hospitalsSt Mary Medical Center, GalesburgJacksonville Memorial Hospital, JacksonvilleMc Donough District Hospital, MacombCarlinville Area Hospital, CarlinvilleMemorial Hospital, CarthageJersey Community Hospital, JerseyvilleGraham Hospital Association, CantonIllini Community Hospital, PittsfieldOsf Holy Family Medical Center, MonmouthSarah D Culbertson Memorial Hospital, RushvilleThomas H Boyd Memorial Hospital, CarrolltonMason District Hospital, HavanaBlessing Hospital
This hospital (dark dot) and the nearest hospitals; dot size shows how many clinicians list each one. Select a dot to open that hospital.

Blessing Hospital

Acute Care Hospitals · Voluntary non-profit - Private

1005 Broadway St
Quincy, IL 62301

Call (217) 223-1200

  • Emergency services
  • Medicare overall rating: 4 of 5 stars

At a glance

Clinicians who list this hospital
586
Physicians (MD and DO)
375
Residents and fellows in training (full-time equivalents, fiscal year 2024)
17
Medical groups
15+

Find a doctor at Blessing Hospital →

Quality and patient experience

Medicare overall rating (of 5)
4
Patient survey rating (of 5)
3
Patients who would definitely recommend it (national average 71%)
67%

Compared with the national rate

MeasuresBetterSameWorse
Deaths after treatment080
Safety of care (infections, complications)250
Readmissions and return visits0110

Number of Medicare quality measures where this hospital’s rate is statistically better than, the same as (no different from), or worse than the national rate.

What patients said

  • Doctors communicated well 2 of 5 stars
  • Nurses communicated well 4 of 5 stars
  • Explained medicines 2 of 5 stars
  • Discharge information 4 of 5 stars
  • Clean 4 of 5 stars
  • Quiet at night 4 of 5 stars

From 431 patient surveys (HCAHPS), period ending 09/30/2025.

Medicare “birthing-friendly” hospital: takes part in a maternity care quality program and follows recommended safety practices.

Source: CMS Care Compare (Hospital General Information; Patient survey HCAHPS). Ratings describe the hospital overall, not individual doctors.

Medical groups whose clinicians work here

Number of each group’s clinicians who list this hospital.

Industry-funded research here

Drug and device companies reported $869,772 in research payments to this hospital in 2025 for 10 studies.

  • Capivasertib plus Palbociclib plus Fulvestrant for HR/HER2 Advanced Breast Cancer CAPItello 292.
    AstraZeneca Pharmaceuticals LP · $355,483
  • A phase 3 randomized double blind placebo controlled study of PF06821497 mevrometostat with enzalutamide in metastatic castration resistant prostate cancer MEVPRO2
    Pfizer Inc. · $194,773
  • Ion Registry BLE Patient Visits Monitoring and Misc Fees
    Intuitive Surgical Operations, Inc. · $105,857
  • A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fi…
    Janssen Research & Development, LLC · $100,440
  • A Phase III Randomized Double blind Multicenter Global Study of Rilvegostomig or Pembrolizumab in Combination with Platinum based Chemotherapy for the First line Treatment of Patients with Metastatic Non squamous Non …
    AstraZeneca Pharmaceuticals LP · $24,000
  • Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
    Ferring Pharmaceuticals As · $24,000 · Recruiting
  • A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination with Cetrelimab Versus Intravesical Bacillus CalmetteGurin (BCG) in Participants with BCG-nave High-Ri…
    Janssen Research & Development, LLC · $23,709
  • A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination with Cetrelimab Versus Intravesical Bacillus CalmetteGurin (BCG) in Participants with BCG-nave High-Ri…
    Janssen Research & Development, LLC · $18,825
  • A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK)
    Janssen Research & Development, LLC · $12,294
  • A Phase III, Randomised, Open-label, Multicentre, Global Study of Datopotamab Deruxtecan (Dato-DXd) in Combination with Durvalumab and Carboplatin Versus Pembrolizumab in Combination with Platinum-based Chemotherapy f…
    AstraZeneca Pharmaceuticals LP · $10,391

From CMS Open Payments research payments to this hospital as a teaching hospital. Payments to affiliated universities or research foundations are reported under those names. All industry-funded trials →

Sources: CMS Hospital General Information and Doctors and Clinicians Facility Affiliation (Care Compare), CMS certification number 140015. Counts are clinicians who list this hospital with Medicare; they include part-time and visiting clinicians and aren’t staff totals. Residents and beds are from the hospital’s Medicare cost report. Ratings are Medicare’s, not ours.